Point72 Hong Kong’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-320
Closed -$6K 1916
2021
Q4
$6K Sell
320
-1,932
-86% -$37.7K ﹤0.01% 1708
2021
Q3
$44K Buy
+2,252
New +$48.7K ﹤0.01% 1549
2020
Q3
Sell
-691
Closed -$12K 1238
2020
Q2
$12K Buy
+691
New +$13.5K ﹤0.01% 955
2019
Q2
Sell
-1,979
Closed -$30K 1158
2019
Q1
$30K Buy
+1,979
New +$31.7K 0.01% 625
2018
Q4
Sell
-2,798
Closed -$41K 937
2018
Q3
$41K Buy
2,798
+2,529
+940% +$44.8K 0.01% 498
2018
Q2
$6K Buy
+269
New +$6.61K ﹤0.01% 693

Other funds holding COLL

Point72 Hong Kong's COLL Position: Q1 2022 in Review

Point72 Hong Kong sold out of Collegium Pharmaceutical (COLL) in Q1 2022, closing a stake of 320 shares — an estimated $6K sold.

Point72 Hong Kong first reported a position in COLL in Q2 2018 and held it in 6 quarters. The position peaked at $44K in Q3 2021. 172 funds tracked by Wall St. Rank hold COLL as of Q1 2022.

  • Point72 Hong Kong reported no remaining Collegium Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 320 Collegium Pharmaceutical shares in Q1 2022, an estimated $6K.
  • Point72 Hong Kong first reported a position in Collegium Pharmaceutical in Q2 2018 and held it in 6 quarters.
  • Point72 Hong Kong's Collegium Pharmaceutical position peaked at $44K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.